Closing Bell Overtime: Pivotal Point for the Rally? 1/17/23
The market is at a pivotal point just as earnings season is getting ready to heat up. But can recent resiliency in stocks really last? Liz Young of Sofi weighs in. Plus, top technician Jonathan Krinsky is flagging two charts that he says are going to head in opposite directions. And, Moderna reported positive news from its RSV vaccine trial. Steve Weiss – a Moderna shareholder – gives his instant reaction.
January 17, 202344m 20s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The market is at a pivotal point just as earnings season is getting ready to heat up. But can recent resiliency in stocks really last? Liz Young of Sofi weighs in. Plus, top technician Jonathan Krinsky is flagging two charts that he says are going to head in opposite directions. And, Moderna reported positive news from its RSV vaccine trial. Steve Weiss – a Moderna shareholder – gives his instant reaction. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.